[A new anti-cancer agent K-18 (conjugate of human IgG and melphalan). (I). K-18 accumulates selectively into the tumor].
D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR
D000970:Antineoplastic Agents; D007074:Immunoglobulin G; C051713:antineoplastic agent K 18; D008558:Melphalan